In this study the effects of CD45 engagement on CD3-TCR-driven stimulation of CD1 + human immature thymocytes have been analyzed. Simultaneous cross-linking of CD45 and CD3 antigens on highly purified CD1 + thymocytes reduced the number of cells undergoing apoptosis after 16 h of In vitro culture. This cell population might represent immature thymocytes committed in vivo to die by programmed cell death (PCD). CD45 engagement could also increase the number of cycling CD1 + thymocytes; of note, the large majority (>95%) of dividing cells expressed the CD1 molecule at the cell surface, indicating that proliferating cells were actually represented by immature thymocytes. These data suggest that the CD45 molecule might play a role in the rescue of immature thymocytes from PCD during differentiation. Along this line, we found that activation of CD1 + thymocytes via the CD3-TCR complex could be enhanced by CD45, both in terms of transcription and surface expression of IL-2R. These effects might be explained by the finding that the CD45 molecule (but not its isoforms CD45RO and RA) was physically associated with the CD3-TCR complex at the cell surface of CD1 + human thymocytes, as shown by co-precipitation and co-capping experiments. Finally, cross-linking of CD45 and CD3 antigens led to the expansion of CD3 + thymocytes co-expressing CD4 and CD8, indicating that simultaneous engagement of CD45 and CD3 
Introduction
It is well known that the membrane tyrosine phosphatase that CD45 is associated with CD3 on murine peripheral CD45 plays a key role in the regulation of lymphocyte activalymphoblasts (6) . This association may explain the reported tion (1) (2) (3) (4) (5) . Extensive studies have been performed both effects of CD45 engagement on CD3-driven intracellular in the murine and human systems on the CD45-mediated calcium [Ca 2+ ]j increase and phosphorylation of protein regulation of lymphocyte signal transduction leading to cell tyrosine kinases (p56 fck and p59^") involved in the proliferation (1) (2) (3) (4) (5) . In particular, it has been demonstrated activation of mature T lymphocytes (7) . Recently, it has + thymocyte activation been demonstrated that the in vivo engagement of the external domains of CD45 can regulate the differentiation of immature CD4 + CD8 + murine thymocytes into mature T cells (8) .
In the human thymus, CD1 + CD4 + CD8 + lymphocytes represent a discrete subpopulation which usually expresses the CD3-TCR at low levels and is unresponsive to stimulation via the CD3-TCR complex (9, 10) . In addition, activation of CD1 + CD4 + CD8 + thymocytes with different stimuli, such as mAb recognizing CD28 or CD2 molecules (in combination with rlL-2 or phorbol esters) results into the expansion of mature CDTCD3 + lymphocytes expressing CD4 or CD8 antigens respectively (9) .
This study was aimed to analyze the effects of CD45 engagement on CD3-TCR-driven stimulation of CD1 + human immature thymocytes. We found that the CD45 molecule (but not its isoforms CD45RO and RA) is physically associated to the CD3-TCR complex at the cell surface of CD1 + human thymocytes. In these cells, the engagement of CD45 antigen reduced the number of apoptotic cells, while increased the number of cycling CD1 + thymocytes. In addition, we observed that activation of CD1 + thymocytes via the CD3-TCR complex could be enhanced by CD45 both in terms of transcription and surface expression of IL-2R. Finally, cross-linking of CD45 and CD3 molecules led to the expansion of CD3 + thymocytes co-expressing CD4 and CD8 antigens. These findings suggest that the CD45 molecule may be involved in the regulation of CD1 + thymocyte differentiation.
Methods

mAb and reagents
The purified anti-CD3 (CBL150), the anti-CD45RO (CBL133) and anti-CD45RA (CBL464) mAb were purchased from Unipath (Milan, Italy). The FITC-conjugated anti-CD25 (anti-IL-2R), the FITC-anti-CD4 (Leu3a), the phycoerythrin (PE)-conjugated anti-CD8 (Leu2a) and the anti-CD3 Leu4 were from Becton Dickinson (Sunnyvale, CA), and the anti-CD1 OKT6 was from Ortho Immune Diagnostic (Mountain View, CA). The anti-HLA class I W6/32 mAb (lgG2a) and the anti-CD45 mAb 9.4 (lgG2a), purchased from ATCC (Rockville, MD), were purified from ascitic fluid by affinity chromatography. The anti-CD45 mAb TA218 (IgM) was produced and purified by chromatography as described (11) . Propidium iodide (PI), RNase type A, EDTA, NP-40, CHAPS, digitonin, Protein G-Sepharose (PGS), para-nitrophenyl phosphate (pNPP) and formaldehyde were obtained from Sigma (St Louis, MO). The purified or alkaline phosphatase (AP)-conjugated goat anti-mouse lgG1 or IgM (GAM) were from Zymed (San Francisco, CA). Guanidine thiocyanate, agarose and CsCI were purchased from BioRad (Milan, Italy). rlL-2 was from Cetus (Amsterdam, The Netherlands). RPMI 1640 medium and FCS were purchased from Biochrom (Berlin, Germany).
Isolation of CD1 + human thymocytes
Human thymus samples were obtained from children (1 month to 4 years old) who had part of the thymus removed during cardiac surgery (Surgical Staff, Ospedale Pediatrico G. Gaslini, Genoa). A single cell suspension was obtained by mincing the thymus and then pressing the fragments through a stainless steel mesh (12) . CD1 + thymocytes were isolated by immunorosetting with ox red blood cells coated with anti-CD 1 mAb as previously described (13) . The purity of the CD1 + cell population was assessed by immunofluorescence on a flow cytometer (see below). Cells were stimulated with either anti-CD3 or anti-CD45 mAb (0.5 ng/10 5 cells) alone or in combination, followed by cross-linking of the molecules obtained with isotype-specific GAM Ig (1 ng/10 5 cells) and cultured in RPMI 1640, supplemented with 10% heatinactivated FCS, at 37°C with 6% CO 2 atmosphere. In some experiments 50 U/ml IL-2 was added to the culture medium . Alternatively, double fluorescence was performed with FITCanti-CD4 and PE-conjugated anti-CD8 mAb. Samples were run on a FACSort (Becton Dickinson) and results expressed as log green fluorescence intensity (a.u., x-axis) versus log red fluorescence intensity (a.u., y-axis) using Lysys II (version 1.1).
Evaluation of apoptosis
Northern blot analysis
Thymocytes were cultured as described above, collected at different time points (1, 6 and 24 h) and frozen at -80°C. Total cellular RNA was extracted from frozen cell pellets (7x10 6 cells) by the guanidine thiocyanate method and purified through a CsCI gradient. RNA (5 ng/sample) was size fractionated on a 1.5% agarose gel containing 0.2 M formaldehyde and transferred by capillary suction onto a charged nylon membrane (GeneScreen Plus; New England Nuclear, NEN, Boston, MA) in 1.5 M NaCI, 0.15 M sodium citrate. The filter was prehybridized and hybridized as described (15) . The DNA probe used, labeled by the random priming technique (16) , was a 0.93 kb fragment of the IL-2R cDNA clone IL-2R (17) .
Co-precipitation of CD3 and CD45 molecules from CD1 + thymocytes
Co-precipitation was evaluated by both SDS-PAGE, after surface labeling, and ELISA as described (18) . For surface labeling, CD1 + thymocytes were iodinated ( 125 I, NEN, 0.5 nCi/10 7 cells) using a standard lactoperoxidase catalyzed reaction. Cells were then lysed in lysis buffer containing either 1% NP-40, 0.5% digitonin or 1% CHAPS, with 10 mM pepstatin, 10 mM aprotinin, 10 mM leupeptin, 10 mM antipain and 10 mM phenylmethylsulfonyl fluoride (Sigma) added, and lysates centrifuged at 13,000 rpm at 4°C For immunoprecipitation, mAb were first coupled to PGS and 100 nl (100 ng protein) of precleared cell lysate were incubated with the pellet beads for 12 h at 4°C under rotation. Beads were washed twice, samples eluted at 50°C for 20 min and run on a 12% SDS-PAGE. Gels were then dried and autoradiographed with appropriate films.
For ELISA on immunoprecipitates, cell lysates were added to 96-well microtiter plates (100 |al/well) coated with 10 ng/ml in PBS (pH 8) of either anti-CD45 (TA218, IgM), anti-CD3 mAb (CBL150-UCHT1, lgG1). To identify coprecipitated proteins, lysates were incubated for 30 min at 4°C with 100 nl mAb (1 ng/ml) directed against CD45 (TA218, IgM), CD3 (UCHT1), CD45RO (CBL133-UCHL1, lgG2a) or HLA class I (W6/32, lgG2a) surface molecules. Isotypespecific AP-GAM (100 ^I/well) was then added to the plates, after extensive washing and the reaction was developed with 100 nl substrate buffer (50 mM Tris-HCI, 1 mg/ml pNPP, pH 9.0). Absorbance of 100 |il supernatants was determined at X = 405 nm with a Titertek Multiscan Analyzer.
Results
CD45 molecule is involved in the rescue from apoptosis of CD1 + immature thymocytes
The large majority of CD1 + immature thymocytes represents a cell population committed to die within the thymus by programmed cell death (PCD) during negative selection processes (19, 20) . In a first series of experiments we observed that the engagement of CD45 molecules by mAb-mediated surface cross-linking (using either TA218 or 9.4 mAb) enhanced both proliferation of human CD1 + thymocytes and Ca 2+ mobilization induced via the CD3-TCR complex (using UCHT1 or Leu4 mAb) (not shown). Thus, we addressed the question of whether CD45 engagement would be capable of preventing CD1 + thymocytes from apoptosis. As shown in Fig. 1(A) , -20% of CD1 + fractionated thymocytes underwent apoptosis within 24 h of culture, as documented by PI uptake (Fig. 1A) . Indeed, apoptotic cells undergoing DNA fragmentation are weakly stained by PI which is able to interact with intact DNA. This cell population might represent immature thymocytes committed in vivo to die by PCD. Treatment with anti-CD45 mAb and anti-CD3 mAb consistently reduced (by 70%) the number of apoptotic cells. This effect was not observed when anti-CD3 mAb was used in combination with anti-LFA-1 or anti-CD44 mAb (not shown). Anti-CD45 mAb alone, as well as anti-CD3 mAb alone, were not effective. It is of note that the number of cells recovered after 24 h under the various culture conditions was similar (not shown). These findings indicate that the simultaneous engagement of CD45 and CD3 molecules can prevent CD1 + thymocytes from apoptosis, suggesting that the CD45 molecule might play a role in the rescue of immature thymocytes from PCD
CD45-mediated regulation of CD1
+ thymocyte activation 1949 during differentiation, possibly leading to CD3 responsiveness.
CD45 engagement induces CD1 + thymocytes to enter the cell cycle
The analysis of cycling cells, after stimulation of CD1 + fractionated thymocytes with anti-CD3 and anti-CD45 mAb, showed that after 24 h of culture -30% of cells were in the S/G 2 /M phase (Fig. 1B) . Conversely, only 6 and 8% of cells were in the S/G 2 /M phase when cultured with medium alone or stimulated with an anti-CD3 mAb respectively (Fig. 1B) . Interestingly, -20% of these cells entered the S/G 2 /M phase by 24 h when cultured with the anti-CD45 mAb alone, supporting the hypothesis that CD45 is involved in early signaling in immature thymocytes. In addition, the large majority (>95%) of dividing cells, after 24 h of culture with anti-CD45 mAb alone or in combination with anti-CD3 mAb, expressed the CD1 molecule at the cell surface (Fig. 1C) , indicating that proliferating cells were actually represented by immature thymocytes. Altogether these findings suggest that CD45 engagement stimulates CD1 + thymocytes to enter the cell cycle and this effect is enhanced by CD3-driven stimulation of this cell population.
Co-stimulation of CD1 + thymocytes with anti-CD45 and anti-CD3 mAb induces both transcription and surface expression of IL-2R
To assess whether CD1 + thymocyte activation led to neotranscription of genes coding for growth factor receptors, we further investigated the effects of the simultaneous engagement of CD45 and CD3 surface molecules on IL-2R mRNA transcription and surface expression.
As shown in Fig. 2(A) , co-stimulation of CD1 + thymocytes with anti-CD3 and anti-CD45 mAb induced the neo-transcription of IL-2R mRNA within 24 h. On the contrary, stimulation with an anti-CD3 mAb alone ( Fig. 2A) , or with anti-CD45 mAb alone (not shown), did not modify the transcription of IL-2R mRNA. Importantly, the engagement of CD3 and CD45 molecules in the presence of exogenous IL-2 induced a strong increase of IL-2R mRNA transcription ( Fig. 2A) , comparable to that found on mature peripheral blood T cells activated with phytohemagglutinin ( Fig. 2A) 
or via CD3 (not shown).
Furthermore, we analyzed whether the IL-2R mRNA transcripts led to de novo expression of IL-2R at the cell surface of CD1 + fractionated thymocytes. As shown in Fig. 2(B) , costimulation with anti-CD3 and anti-CD45 mAb induced a strong de novo expression of IL-2R, compared to the stimulation with anti-CD3 mAb alone. Again, the addition of exogenous IL-2 led to a further increase of IL-2R expression. These findings indicate that the engagement of CD3 together with CD45 induces the activation of CD1 + immature thymocytes, possibly leading to cell proliferation through an autocrine and/or paracrine mechanism.
CD45 antigen is physically associated with CD3 at the cell surface of CD1 + thymocytes
To explain the co-stimulatory effect exerted by anti-CD45 and anti-CD3 mAb on CD1 + thymocytes we further investigated whether CD45 molecules were associated to CD3-TCR complex. As shown in Fig. 3(A) , a band with a M r corresponding + thymocyte activation to that of CD3 (compare lanes 8 and 3) was detectable after immunoprecipitation with an anti-CD45 mAb of cell lysates obtained from freshly isolated CD1 + thymocytes using a buffer with 0.5% CHAPS added. Co-precipitation of CD45 and CD3 was also observed in a solid-phase ELISA (Fig. 3B) . Physical association of the two molecules was more evident when cell lysates were immunoprecipitated with anti-CD3 and immunostaining performed with anti-CD45 mAb (Fig. 3C) . In addition, CD3 molecules were not physically associated with other surface molecules including HLA class I, CD45RO (Fig. 3C ) and LFA-1 or CD45RA isoform (not shown). Our results suggest that CD3 molecules preferentially associates with CD45 at the surface of CD1 + thymocytes. This was also supported by the finding that CD3 antigen selectively colocalized with CD45 molecule in co-capping experiments using specific mAb (not shown).
CD45 engagement on CD1
+ thymocytes led to preferential expansion of CD3 + CD4 + CD8 + thymocytes We further addressed the question of whether simultaneous CD3 and CD45 engagement could lead to preferential expansion of a thymocyte population showing phenotypic and functional features different from cell populations stimulated via CD3-TCR alone. Double immunofluorescence analysis, at day 10, of CD1 + thymocytes co-stimulated with anti-CD3 and anti-CD45 mAb and cultured with IL-2 showed that the large majority (>80%) of these cells co-expressed CD4 and CD8 antigens while a small fraction (<10%) was alternatively CD4 + or CD8 + (Fig. 4D ). All these cells co-expressed a functional CD3 molecule, as sorted CD3 + CD4 + CD8 + cells were found to produce IL-2 and exert a strong cytolytic activity upon activation with anti-CD3 mAb (not shown). On the contrary stimulation with the anti-CD3 mAb alone led to proliferation of cells mainly expressing either CD4 or CD8 molecules. In this case CD4 + CD8 + cells were a minor fraction (<10%) of cells recovered (Fig. 4B) . When CD1 + cells were challenged with the anti-CD45 mAb alone, about one-third of the resulting cell population co-expressed CD4 and CD8 antigens (Fig. 4C) . These findings suggest that the simultaneous engagement of CD45 and CD3 molecules can block CD1 + cells at the double-positive (CD4 + CD8 + ) differentiation stage, leading to Immunodetection was performed as described in Methods with 100 ^ mAb (1 ng/ml) directed against CD45, CD45RO, CD3 or HLA class I surface molecules. Isotype-specific AP-GAM (100 nl/well) was then added to the plates and reaction was developed with the appropriate substrate buffer. Absorbance was measured at X = 405 nm. Similar results were obtained in three independent experiments.
Interestingly, the engagement of CD45 molecules influenced the CD3-TCR-driven stimulation of CD1 + thymocytes leading to the expansion of functional CD3 + cells co-expressing CD4
and CD8 co-receptors. The finding that CD45 was selectively associated with CD3 antigens, but not with other surface + thymocyte activation
Log Green Fluorescence Intensity (a.u.) molecules such as LFA-1 or HLA class I, could explain the observed effects on CD1 + activation. Our data are in agreement with the report in mouse that there is a physical association between the CD3-TCR complex and CD45 molecules (6) .
It is tempting to speculate that the simultaneous engagement of CD45 and the CD3-TCR complex may play a role in the selection processes that occur within the thymus. The presence of natural ligands for CD45 molecules on the cell surface of epithelial cells or other non-lymphoid cells could determine the fate of CD1 + thymocytes when their CD3-TCR complex interacts with self MHC molecules within the thymus. It should be noted that, in our experimental system, CD45 engagement could affect the CD3-TCR-driven activation of CD1 + cells, but not their activation mediated by co-receptor molecules such as CD28 and CD2 (not shown). This would support the concept that CD45 molecules may regulate the differentiation of CD1 + thymocytes. Indeed, the engagement of CD3-TCR at the surface of immature thymocytes has been reported to induce either apoptosis or clonal expansion depending on the affinity of the CD3-TCR complex to self MHC molecules (19, 20) . Along this line, CD45 might prevent CD1 + thymocytes from PCD, leading to a transient arrest in an 'intermediate' differentiation stage (CD4 + CD8 + phenotype), in order to allow the appropriate interaction between the CD3-TCR complex and self MHC. This possible interpretation of our results is further supported by recent data showing that injection of anti-CD45 mAb could block thymocyte differentiation into mature CD4 + or CD8 + T cells in mice (8) . Furthermore, the engagement of CD45-linked oligosaccharides by the serum mannan binding protein has been reported to prevent CD3-TCR-induced apoptosis of immature thymocytes in mice (21) .
In conclusion, our data support the hypothesis that, in humans, the CD45 molecule is involved both in early activation and differentiation of CD1 + thymocytes. The identification of the natural CD45 ligand (operating in vivo) would further elucidate the molecular mechanism underlying the role of CD45 in the regulation of thymocyte differentiation.
